BV-AVD-R Treatment Children Hodgkin's Lymphoma

NCT06201507 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Hodgkin Lymphoma

Interventions

DRUG: Brentuximab vedotin
DRUG: Rituximab
DRUG: Doxorubicin
DRUG: Vincristine
DRUG: Dacarbazine

Sponsor

Beijing Children's Hospital